research Cutaneous Syndromes Produced as Side Effects of Triparanol Therapy
Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.
Search
for
Sort by
Research
990-1000 / 1000+ results research A study on the protective efficacy and cell proliferation of dermal papilla cells by spirulina extract
Spirulina extract may help protect the scalp and improve hair growth.
research Photoprotective Effects of Caffeic Acid against Ultraviolet-induced Damages on Human Follicle Dermal Papilla Cells
Caffeic acid protects human scalp cells from UV damage.
research Nanostructured Ayurvedic Emulsion of Bakuchiol & Neem Oil for Mild‑to‑Moderate Alopecia Areata Open‑Label Single‑Arm Pilot Study
The treatment with Bakuchiol and Neem oil significantly improved hair growth and was well-received by most participants.
research 709 Nitric oxide-releasing topical therapeutic agent for atopic dermatitis
SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.
research EFFICACY AND SAFETY EVALUATION OF SESA OIL VS COCONUT OIL IN DIFFERENT HAIR & SCALP AILMENTS: PROSPECTIVE, OPEN LABEL, RANDOMIZED COMPARATIVE STUDY
SESA oil is five times more effective and safe for hair and scalp issues than coconut oil.
research Encapsulación en ciclodextrinas de compuestos con actividad frente a la alopecia androgénica masculina.
Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.
research Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
research Acute, diffuse and total alopecia
Two lotions used day and night may be a good alternative to minoxidil for hair loss, with better cosmetic effects and tolerance.
research Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors and baricitinib: A case report and literature review
A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.